MedPath

The effect of hesperidin in the treatment of diabetes

Phase 3
Conditions
diabet.
Non-insulin-dependent diabetes mellitus
Registration Number
IRCT201407242602N12
Lead Sponsor
Iran University Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
48
Inclusion Criteria

Being volunteer or Wishing to attend 2.diagnosed with type 2 diabetes for at least 1 year (FPG = 126 mg/dl or 2hPG = 200 mg/dl)3. At least one year history of diabet 4.
Not using tobacco 5. Lack of cardiovascular disease, liver disease, kidney disease, chronic inflammatory disease of the gastrointestinal tract 6.HbA1C < 8% 7. 20-65 y old 8. Lack of insulin 9. Not drinking alcohol 10. BMI<35 kg/m2 11. Not using any supplements, antioxidants and vitamins in the last 3 months 12. Not pregnant or nursing 13.TG<400 mg/dl 14. The absence of any skin allergies or digestive antioxidant supplements and vitamins. Exclusion criteria 1.The use of antioxidant supplements and vitamins 2.Use of insulin 3. See allergy symptoms at any time during the study 4.Taking over500ml beverages rich in flavonoids include tea, coffee, citrus juice, which it is determined by taking the 24-hour dietary recalls 5. Accept less than 70 6. Follow weight loss diets 7. NSAID nonsteroidal anti-inflammatory drugs and estrogens, oral contraceptives, anticonvulsants, corticosteroids

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath